Literature DB >> 18090279

Serological testing algorithm shows rising HIV incidence in a UK cohort of men who have sex with men: 10 years application.

Martin Fisher1, David Pao, Gary Murphy, Gillian Dean, Denis McElborough, Gary Homer, John V Parry.   

Abstract

OBJECTIVES: To investigate whether combining clinical data with the serological testing algorithm for recent HIV seroconversion (STARHS) reliably identifies otherwise unrecognized recent infections and observe their trends.
DESIGN: Incorporation of STARHS into routine HIV diagnosis.
METHODS: STARHS was applied to serum collected between 1996 and 2005 at HIV diagnosis and routine clinical/laboratory markers of recent infections were determined. The recent infections were identified by conventional means, by STARHS, and by both combined.
RESULTS: Of 1526 infections diagnosed, 812 were new. Of these, 604 were in men who have sex with men (MSM); 208 in heterosexuals; 88% had serum available for STARHS, which identified 88 incident infections that would otherwise have been unrecognized (12% of all new infections, 34% of all recent infections). Of these, 88% reported recent high-risk sex; 47% reported seroconversion symptoms. STARHS confirmed recent infections in 71 of 74 (96%) known to be infected within 6 months by conventional methods. Combining both approaches, recent infections increased over time from 26% (1996) to 45% (2005) [P < 0.001]. STARHS results from 3% new diagnoses and 8% previous diagnoses were deemed false incident (associated with antiretroviral therapy, advanced disease or undetectable viral load). False incident results were only inexplicable in two individuals.
CONCLUSION: Adjunctive use of STARHS with clinical data identified a high and increasing proportion of new HIV diagnoses as recent infections, confirming significant ongoing transmission. Since 2002, 50% of new diagnoses among MSM were recent infections. Identification of additional recent infections by STARHS enables effective intervention that may benefit the individual and reduce onward transmission.

Entities:  

Mesh:

Year:  2007        PMID: 18090279     DOI: 10.1097/QAD.0b013e3282ef9fed

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Perceptions of Human Papillomavirus (HPV) infection and acceptability of HPV vaccine among men attending a sexual health clinic differ according to sexual orientation.

Authors:  Massimo Giuliani; Maria Fenicia Vescio; Maria Gabriella Donà; Alessandra Latini; Mirko Frasca; Manuela Colafigli; Massimo Farinella; Giovanni Rezza; Antonio Cristaudo
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

2.  Evaluation of HIV incidence surveillance in New York City, 2006.

Authors:  Hemanth P Nair; Lucia V Torian; Lisa Forgione; Elizabeth M Begier
Journal:  Public Health Rep       Date:  2011 Jan-Feb       Impact factor: 2.792

3.  High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland.

Authors:  Magdalena Rosińska; Anna Marzec-Bogustawska; Janusz Janiec; Joanna Smoleń-Dzirba; Tomasz Wąsik; Joanna Gniewosz; Małgorzata Zalewska; Gary Murphy; Elaine McKinney; Kholoud Porter
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-26       Impact factor: 2.205

4.  Transmission networks of drug resistance acquired in primary/early stage HIV infection.

Authors:  Bluma G Brenner; Michel Roger; Daniela D Moisi; Maureen Oliveira; Isabelle Hardy; Reuven Turgel; Hugues Charest; Jean-Pierre Routy; Mark A Wainberg
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

Review 5.  Current and future assays for identifying recent HIV infections at the population level.

Authors:  Joanna Smoleń-Dzirba; Tomasz J Wąsik
Journal:  Med Sci Monit       Date:  2011-05

6.  Epidemiological study of phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between subtype B and non-B infections.

Authors:  Kristen Chalmet; Delfien Staelens; Stijn Blot; Sylvie Dinakis; Jolanda Pelgrom; Jean Plum; Dirk Vogelaers; Linos Vandekerckhove; Chris Verhofstede
Journal:  BMC Infect Dis       Date:  2010-09-07       Impact factor: 3.090

7.  Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy.

Authors:  Lavinia Fabeni; Claudia Alteri; Nicoletta Orchi; Caterina Gori; Ada Bertoli; Federica Forbici; Francesco Montella; Alfredo Pennica; Gabriella De Carli; Massimo Giuliani; Fabio Continenza; Carmela Pinnetti; Emanuele Nicastri; Francesca Ceccherini-Silberstein; Claudio Maria Mastroianni; Enrico Girardi; Massimo Andreoni; Andrea Antinori; Maria Mercedes Santoro; Carlo Federico Perno
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

8.  Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM.

Authors:  Andrew N Phillips; Valentina Cambiano; Alec Miners; Fiona C Lampe; Alison Rodger; Fumiyo Nakagawa; Alison Brown; O Noel Gill; Daniela De Angelis; Jonathan Elford; Graham Hart; Anne M Johnson; Jens D Lundgren; Simon Collins; Valerie Delpech
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

9.  Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic.

Authors:  Andrew N Phillips; Valentina Cambiano; Fumiyo Nakagawa; Alison E Brown; Fiona Lampe; Alison Rodger; Alec Miners; Jonathan Elford; Graham Hart; Anne M Johnson; Jens Lundgren; Valerie C Delpech
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

10.  Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests.

Authors:  Helena Skar; Jan Albert; Thomas Leitner
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.